Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Cash Flow Quality Index
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow Quality Index of -1.00x as of December 2024. Operating cash flow of CN¥-60.52 Million is below net income of CN¥60.45 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Shandong Keyuan Pharmaceutical Co. Ltd. (301281) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Quality Index (2021–2024)
Historical Cash Flow Quality Index for Shandong Keyuan Pharmaceutical Co. Ltd. A across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Shandong Keyuan Pharmaceutical Co. Ltd. cash conversion from operations.
Annual Cash Flow Quality Index for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
Year-by-year earnings quality comparison for Shandong Keyuan Pharmaceutical Co. Ltd. A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.00x | CN¥-60.52 Million | CN¥60.45 Million | ▼ -308.3% |
| 2023 | 0.48x | CN¥37.03 Million | CN¥77.04 Million | ▼ -62.1% |
| 2022 | 1.27x | CN¥115.86 Million | CN¥91.28 Million | ▲ +90.7% |
| 2021 | 0.67x | CN¥52.02 Million | CN¥78.17 Million | — |